Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

211At- and 131I-Labeled Bisphosphonates with High In Vivo Stability and Bone Accumulation

Roy H. Larsen, Kristin M. Murud, Gamal Akabani, Per Hoff, Øyvind S. Bruland and Michael R. Zalutsky
Journal of Nuclear Medicine July 1999, 40 (7) 1197-1203;
Roy H. Larsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin M. Murud
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gamal Akabani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per Hoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Øyvind S. Bruland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael R. Zalutsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 40, Issue 7
July 1, 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
211At- and 131I-Labeled Bisphosphonates with High In Vivo Stability and Bone Accumulation
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
211At- and 131I-Labeled Bisphosphonates with High In Vivo Stability and Bone Accumulation
Roy H. Larsen, Kristin M. Murud, Gamal Akabani, Per Hoff, Øyvind S. Bruland, Michael R. Zalutsky
Journal of Nuclear Medicine Jul 1999, 40 (7) 1197-1203;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
211At- and 131I-Labeled Bisphosphonates with High In Vivo Stability and Bone Accumulation
Roy H. Larsen, Kristin M. Murud, Gamal Akabani, Per Hoff, Øyvind S. Bruland, Michael R. Zalutsky
Journal of Nuclear Medicine Jul 1999, 40 (7) 1197-1203;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The {alpha}-Camera: A Quantitative Digital Autoradiography Technique Using a Charge-Coupled Device for Ex Vivo High-Resolution Bioimaging of {alpha}-Particles
  • High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the {alpha}-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities?
  • First Clinical Experience with {alpha}-Emitting Radium-223 in the Treatment of Skeletal Metastases
  • Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 1: Effects of Solvent on the Degradation of Radiohalogenation Precursors by 211At {alpha}-Particles
  • 123I-Labeled Chitinase as Specific Radioligand for In Vivo Detection of Fungal Infections in Mice
  • Targeting of Osseous Sites with {alpha}-Emitting 223Ra: Comparison with the {beta}-Emitter 89Sr in Mice
  • Significant Antitumor Effect from Bone-seeking, {alpha}-Particle-emitting 223Ra Demonstrated in an Experimental Skeletal Metastases Model
  • Overcoming the Obstacles to Clinical Evaluation of 211At-Labeled Radiopharmaceuticals
  • Google Scholar

More in this TOC Section

  • Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study
  • [11C]ZTP-1: An Effective Short-Lived Radioligand for PET of Rat and Monkey Brain Phosphodiesterase Type 4 Subtype B
  • Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model
Show more Basic Science Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire